ĀÜĄņĀŅĀ×

Caroline J Loew, PhD is currently the CEO of Mural Oncology. Previously, Caroline J served as a Strategic Advisor | Consultant and President and CEO at Glympse Bio. Before that, Caroline J held the position of Vice President, Head of R&D Strategy and Planning at Bristol-Myers Squibb and Vice President, Late Lifecycle Management and Loss of Exclusivity Center of Excellence at Merck. Caroline has also worked as the Vice President of Customer Value and Health Technology Assessment at Merck and as a Senior Vice President at PhRMA. Caroline J holds a PhD in Organic Chemistry and a Bachelor of Science in Chemistry from Imperial College London.